Quick Contact

    Jeff Lindsay

    Senior Advisor

    Jeff Lindsay - ipCG

    Education

    Ph.D. in Chemical Engineering from Brigham Young University (BYU) in Provo, Utah. Fellow of the American Institute of Chemical Engineers (AICHE).

    Reads, writes, and speaks Mandarin Chinese and also speaks some German and Hmong.

    Biography

    Jeff Lindsay’s career has focused on innovation, invention, and IP protection with experience in academia, large corporations in both the US and Asia, a rapidly growing startup, and a service provider. Jeff seeks to overcome the many potential gaps between inventors and their employers as well as the gaps between corporate knowledge and the emerging possibilities in their field. Every year since 2015, Jeff has been named as “one of the world’s leading IP strategists” in the IAM Strategy 300 publication by IAM Media. Some of Jeff’s approaches are described in Conquering Innovation Fatigue (John Wiley & Sons, 2009) by Jeff Lindsay, Cheryl Perkins, and Mukund Karanjikar.

    Most recently served as Head of R&D and IP at Lume Deodorant, a startup focused on science-based consumer products for which Jeff wrote their initial patents and more recently created further IP and new product opportunities in his role there from 2019 to 2020. From 2011 to 2019, Jeff was the Head of IP at Asia Pulp & Paper (APP) in Shanghai, one of the largest paper companies in the world and part of what may be the world’s largest family-owned company, Sinar Mas out of Jakarta, Indonesia. At APP, Jeff led a team of six IP professionals in protecting APP’s brands and in providing guidance on innovation strategy.

    Jeff is also the former Corporate Patent Strategist and Senior Research Fellow for Kimberly-Clark (K-C), where he helped guide IP strategy for K-C’s many patent filing groups. At K-C, Jeff believed one of his major accomplishments was bringing the power of ipCapital Group to Kimberly-Clark to implement the Invention on Demand system and to rapidly accelerate K-C’s IP strategy. Significant IP estates were created in several areas such as RFID, business tools involving virtual and augmented reality, and a variety of emerging technologies.

    Following K-C, Jeff served as a Director at Innovationedge, a consultancy led by K-C’s former Chief Innovation Officer, Cheryl Perkins. At Innovationedge Jeff assisted companies in IP strategy, technology transfer, and technology scouting.

    Jeff is a former professor at the Institute of Paper Science and Technology (now RBI) at Georgia Tech. He is a registered US patent agent and inventor with 130 US patents. Current interests and projects include consumer product formulation, novel uses of natural ingredients in consumer products, biofilm control, odor control, facial recognition and customizable security systems using the “Private Rules” approach that he has patented.

    Jeff has a Ph.D. in Chemical Engineering from Brigham Young University (BYU) in Provo, Utah and is a Fellow of the American Institute of Chemical Engineers (AICHE). Jeff serves as a board member and a Vice President of the Interpreter Foundation (Salt Lake City, Utah). He has also served as an advisor to the Utah-Qinghai Ecopartnership and as board member for the Huang Yi Cong Foundation, one of China’s leading charitable foundations which is largely funded by APP and its employees.

    Jeff reads, writes, and speaks Mandarin Chinese and also speaks some German and Hmong.

    Articles

    UK Court Ruling Shakes Up AI Patentability Standards

    The UK Court of Appeal’s decision on Emotional Perception’s patent application is pivotal for AI innovations, establishing that AI inventions, such as artificial neural networks (ANNs), are considered computer programs and thus excluded from patentability. This ruling aligns the UKIPO with the EPO’s approach, emphasizing that AI inventions must demonstrate a technical effect beyond computer implementation to be patentable. Consequently, companies must reassess their intellectual property strategies to ensure robust protection of their AI technologies.

    Breaking News in Pharma Patents: What You Need to Know to Stay Ahead

    Today, I’m going to break down some major developments in the pharma patent world and what they mean for your IP strategy. The FTC’s Crackdown on “Junk” Patents: What You Must Do The FTC is on a mission to clean up what they call “junk” drug patents listed in the FDA’s Orange Book. They’ve got […]

    From Classroom to Boardroom: University Patents – Purdue Case Study

    Purdue University is killing it in the patents game. In 2023, they ranked 5th among U.S. universities for U.S. patents, scoring 198 patents. That’s no small feat. The Power of University Patents Universities are a powerhouse of innovation. In some tech sectors, up to 25% of all patents are filed by universities. Think about that. […]